Screening for lung cancer in NZ is highly unlikely to be cost-effective: New NZ study

Monday, September 3rd, 2018 | dayhi34p | No Comments

Dr Richard Jaine, Dr Giorgi Kvizhinadze, Prof Nick Wilson, Prof Tony Blakely

There is reasonably strong evidence screening for lung cancer with low-dose computed tomography (LDCT) scans is effective at reducing lung cancer mortality. However, new research suggests it is highly unlikely to be cost-effective in NZ. We have just published the first NZ study to examine the cost-effectiveness of lung cancer screening in the journal Lung Cancer, and we estimate that it would cost NZ$154,000 per quality-adjusted life-year (QALY) gained – even among heavy smokers [1]. This means that gaining the equivalent of one year of life in perfect health from lung cancer screening comes with a price tag of about $150,000. This suggests that if we want to reduce the burden of lung cancer in NZ but still have to work within a finite health budget, we should consider more cost-effective means (e.g. enhanced tobacco control).

Continue reading

Can CT screening for lung cancer in New Zealand be cost-effective?

Monday, September 28th, 2015 | Kate Sloane | 5 Comments

Dr Richard Jaine, Dr Nisha Nair and Professor Tony Blakely

CT screening for lung cancer -1There is now strong evidence that screening for lung cancer with low-dose computed tomography (LDCT) scans is effective at reducing lung cancer mortality. So why aren’t countries rushing to introduce a screening programme? Because there is still doubt about its cost-effectiveness. In this blog, we discuss the uncertainties and suggest a way forward for New Zealand.

Continue reading